Article ISI SCOPUS
LANCET  (2016)

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Khatib R.; McKee M.; Shannon H.; Chow C.; Rangarajan S.; Teo K.; Wei L.; Mony P.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Diaz R.; Avezum A.; Lanas F.; et. al.

Más información

Título según WOS: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Título según SCOPUS: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
Título de la Revista: LANCET
Volumen: 387
Número: 10013
Editorial: Elsevier Science Inc.
Fecha de publicación: 2016
Página de inicio: 61
Página final: 69
Idioma: English
DOI:

10.1016/S0140-6736(15)00469
Notas: ISI, SCOPUS